Cargando…

Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis

BACKGROUND: The World Health Organization (WHO) report stated that Acinetobacter baumannii had been classified as one of the most important pathogenic bacteria causing nosocomial infection in hospital patients due to multi-drug resistance (MDR). It is vital to find out new bacterial drug targets and...

Descripción completa

Detalles Bibliográficos
Autores principales: Amera, Gizachew Muluneh, Khan, Rameez Jabeer, Jha, Rajat Kumar, Pathak, Amita, Muthukumaran, Jayaraman, Singh, Amit Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387395/
https://www.ncbi.nlm.nih.gov/pubmed/32725318
http://dx.doi.org/10.1186/s43141-020-00048-4
_version_ 1783564110342914048
author Amera, Gizachew Muluneh
Khan, Rameez Jabeer
Jha, Rajat Kumar
Pathak, Amita
Muthukumaran, Jayaraman
Singh, Amit Kumar
author_facet Amera, Gizachew Muluneh
Khan, Rameez Jabeer
Jha, Rajat Kumar
Pathak, Amita
Muthukumaran, Jayaraman
Singh, Amit Kumar
author_sort Amera, Gizachew Muluneh
collection PubMed
description BACKGROUND: The World Health Organization (WHO) report stated that Acinetobacter baumannii had been classified as one of the most important pathogenic bacteria causing nosocomial infection in hospital patients due to multi-drug resistance (MDR). It is vital to find out new bacterial drug targets and annotated their structure and function for the exploration of new anti-bacterial agents. The present study utilized a systematic route to prioritize the potential drug targets that belong to Mur family of Acinetobacter baumannii and identify their homologous proteins using a computational approach such as sequence similarity search, multiple sequence alignment, phylogenetic analysis, protein sequence, and protein structure analysis. RESULTS: From the results of protein sequence analysis of eight Mur family proteins, they divided into three main enzymatic classes namely transferases (MurG, MurA and MraY), ligases (MurC, MurD, MurE, and MurF), and oxidoreductase (MurB). Based on the results of intra-comparative protein sequence analysis and enzymatic classification, we have chosen MurB, MurE, and MurG as the prioritized drug targets from A. baumannii and subjected them for further detailed studies of inter-species comparison. This inter-species comparison help us to explore the sequential and structural properties of homologous proteins in other species and hence, opens a gateway for new target identification and using common inhibitor for different bacterial species caused by various diseases. The pairwise sequence alignment results between A. baumannii’s MurB with A. calcoaceticus’s MurB, A. baumannii’s MurE with A. seifertii’s MurE, and A. baumannii’s MurG with A. pittii’s MurG showed that every group of the proteins are highly similar with each other and they showed sequence identity of 95.7% and sequence similarity of 97.2%. CONCLUSION: Together with the results of secondary and three-dimensional structure predictions explained that three selected proteins (MurB, MurE, and MurG) from A. baumannii and their related proteins (AcMurB, AsMurE, and ApMurG) belong to mixed αβ class and they are very similar.
format Online
Article
Text
id pubmed-7387395
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73873952020-08-11 Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis Amera, Gizachew Muluneh Khan, Rameez Jabeer Jha, Rajat Kumar Pathak, Amita Muthukumaran, Jayaraman Singh, Amit Kumar J Genet Eng Biotechnol Research BACKGROUND: The World Health Organization (WHO) report stated that Acinetobacter baumannii had been classified as one of the most important pathogenic bacteria causing nosocomial infection in hospital patients due to multi-drug resistance (MDR). It is vital to find out new bacterial drug targets and annotated their structure and function for the exploration of new anti-bacterial agents. The present study utilized a systematic route to prioritize the potential drug targets that belong to Mur family of Acinetobacter baumannii and identify their homologous proteins using a computational approach such as sequence similarity search, multiple sequence alignment, phylogenetic analysis, protein sequence, and protein structure analysis. RESULTS: From the results of protein sequence analysis of eight Mur family proteins, they divided into three main enzymatic classes namely transferases (MurG, MurA and MraY), ligases (MurC, MurD, MurE, and MurF), and oxidoreductase (MurB). Based on the results of intra-comparative protein sequence analysis and enzymatic classification, we have chosen MurB, MurE, and MurG as the prioritized drug targets from A. baumannii and subjected them for further detailed studies of inter-species comparison. This inter-species comparison help us to explore the sequential and structural properties of homologous proteins in other species and hence, opens a gateway for new target identification and using common inhibitor for different bacterial species caused by various diseases. The pairwise sequence alignment results between A. baumannii’s MurB with A. calcoaceticus’s MurB, A. baumannii’s MurE with A. seifertii’s MurE, and A. baumannii’s MurG with A. pittii’s MurG showed that every group of the proteins are highly similar with each other and they showed sequence identity of 95.7% and sequence similarity of 97.2%. CONCLUSION: Together with the results of secondary and three-dimensional structure predictions explained that three selected proteins (MurB, MurE, and MurG) from A. baumannii and their related proteins (AcMurB, AsMurE, and ApMurG) belong to mixed αβ class and they are very similar. Springer Berlin Heidelberg 2020-07-28 /pmc/articles/PMC7387395/ /pubmed/32725318 http://dx.doi.org/10.1186/s43141-020-00048-4 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research
Amera, Gizachew Muluneh
Khan, Rameez Jabeer
Jha, Rajat Kumar
Pathak, Amita
Muthukumaran, Jayaraman
Singh, Amit Kumar
Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title_full Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title_fullStr Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title_full_unstemmed Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title_short Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
title_sort prioritization of mur family drug targets against a. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387395/
https://www.ncbi.nlm.nih.gov/pubmed/32725318
http://dx.doi.org/10.1186/s43141-020-00048-4
work_keys_str_mv AT ameragizachewmuluneh prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis
AT khanrameezjabeer prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis
AT jharajatkumar prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis
AT pathakamita prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis
AT muthukumaranjayaraman prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis
AT singhamitkumar prioritizationofmurfamilydrugtargetsagainstabaumanniiandidentificationoftheirhomologousproteinsthroughmolecularphylogenyprimarysequenceandstructuralanalysis